x
Breaking News
0

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
71.21 -0.71    -0.99%
14:17:07 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US3755581036 
CUSIP: 375558103
  • Volume: 1,796,658
  • Bid/Ask: 71.21 / 71.22
  • Day's Range: 71.14 - 72.17
START TRADING NOW
Gilead 71.21 -0.71 -0.99%

GILD Overview

 
Information about the Gilead Sciences Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close71.92
Day's Range71.14 - 72.17
Revenue29.1B
Open72.04
52 wk Range63.76 - 88.85
EPS9.46
Volume1,796,658
Market Cap93.98B
Dividend (Yield)1.93 (2.89%)
Average Vol. (3m)8,565,229
P/E Ratio7.6
Beta1.23
1-Year Change - 12.62%
Shares Outstanding1,306,728,398
Next Earnings DateJul 24, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Neutral Buy Buy Buy
Technical Indicators Strong Sell Sell Strong Buy Strong Buy Strong Sell
Summary Strong Sell Neutral Strong Buy Strong Buy Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Down 1H Current
Engulfing Bearish 5H Current
Bullish Engulfing 1M Current
Completed Patterns
Engulfing Bearish 1H 1 Jun 29, 2017 09:00AM
Three Black Crows 15 1 Jun 29, 2017 10:00AM
Engulfing Bearish 1D 2 Jun 27, 2017

Gilead Sciences Inc News & Analysis

News


Gilead Sciences Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 71.21 71.21 71.22 1,796,658 -0.99% USD 14:17:07  
  Mexico 1,286.02 1,109.02 1,329.98 0 0.00% MXN 28/06  
  Switzerland 69.000 62.000 69.900 0 0% CHF 23/06  
  Switzerland 64.700 0.000 0.000 0 0% USD 23/05  
  Frankfurt 62.95 62.43 62.48 3,239 +0.22% EUR 13:49:00  
  Berlin 62.950 62.460 62.520 150 +1.11% EUR 13:51:00  
  TradeGate 62.49 62.31 62.37 6,470 -1.20% EUR 14:02:00  
  Munich 63.030 62.450 62.510 0 +0.80% EUR 06:01:00  
  Stuttgart 62.900 62.430 62.490 2,797 -0.36% EUR 13:52:00  
  Vienna 62.850 0.000 0.000 0 0.00% EUR 28/06  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tesla 363.72 371.00 363.00 -7.52 -2.03% 1.49M 14:17:07  
  Apple 144.04 145.13 143.97 -1.79 -1.23% 5.65M 14:16:56  
  Bank of America 24.41 24.67 24.36 +0.53 +2.23% 41.17M 14:16:54  
  Spherix 4.0000 4.2500 2.8300 +2.0900 +109.42% 17.46M 14:16:49  
  Amazon.com 978.07 987.56 977.10 -12.26 -1.24% 795.25K 14:17:01  
  Rite Aid 3.025 3.110 2.880 -0.905 -23.03% 83.17M 14:16:47  
  JPMorgan 91.50 92.65 91.34 +1.68 +1.87% 7.48M 14:17:01  
  Alibaba 141.90 143.56 141.78 -2.05 -1.42% 3.21M 14:16:58  
  AMD 12.890 13.150 12.820 -0.340 -2.57% 19.55M 14:17:04  
  NVIDIA 147.38 150.72 147.17 -4.37 -2.88% 5.10M 14:17:00  

Gilead Sciences Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

9000

Equity Type

ORD

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Securities and Exchange Commission (United States) Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest GILD Comments

Episcopolian OptionTrader
Episcopolian1 Mar 17, 2017 1:46PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price target raised to $110
Episcopolian OptionTrader
Episcopolian1 Mar 10, 2017 2:33PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GILD is about to announce a huge acquisition. Buy it before that happens. $100 price target!.
Danny Alasha
Danny Alasha Dec 30, 2016 5:57PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job pop star, I see head and shoulders here but despite, 2017 pick
Show more comments
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google+
or
Sign up with Email